WINDTREE THERAPEUTICS INC /DE/ Temporary Equity, Dividends, Adjustment
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Temporary Equity, Dividends, Adjustment of $998.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityDividendsAdjustment · last filed 2025-05-15
- WINDTREE THERAPEUTICS INC /DE/ temporary equity, dividends, adjustment for the quarter ending 2025-03-31 was $998.00K.
- WINDTREE THERAPEUTICS INC /DE/ temporary equity, dividends, adjustment for the quarter ending 2024-12-31 was $2.05M.
- WINDTREE THERAPEUTICS INC /DE/ temporary equity, dividends, adjustment for the quarter ending 2024-09-30 was $1.57M.
- WINDTREE THERAPEUTICS INC /DE/ temporary equity, dividends, adjustment for the quarter ending 2024-03-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ temporary equity, dividends, adjustment for fiscal 2024 was $3.62M.
- WINDTREE THERAPEUTICS INC /DE/ temporary equity, dividends, adjustment for fiscal 2023 was $0.00.
| Period end | Temporary Equity, Dividends, Adjustment 3 month | Temporary Equity, Dividends, Adjustment 6 month | Temporary Equity, Dividends, Adjustment 9 month | Temporary Equity, Dividends, Adjustment 12 month |
|---|---|---|---|---|
| 2025-03-31 | $998.00K 10-Q · filed 2025-05-15 | $3.05M derived: sum of 2 quarters · filed 2025-05-15 | $4.62M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2024-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $3.62M derived: sum of 2 quarters · filed 2025-04-15 | $3.62M 10-K · filed 2025-04-15 | |
| 2024-09-30 | $1.57M 10-Q · filed 2024-11-26 | $1.57M 10-Q · filed 2024-11-26 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $0.00 derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-26 | $0.00 10-Q · filed 2024-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |